Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaus Marx

Showing results (11-20 of 566) with videos related to

Pageof 57
Sort By:
Deutsche Medizinische Wochenschrift (1946)|July 16, 2020
[Antithrombotic therapy in cardiovascular diseases]Nikolaus Marx
Cardiovascular Endocrinology & Metabolism|October 25, 2019
Heart failure: an underestimated therapeutic target in diabetesNikolaus Marx
Diabetes & Vascular Disease Research|October 30, 2008
PERISCOPE and the effect of pioglitazone on the progression of coronary artery disease in patients with diabetesNikolaus Marx
Herz|March 22, 2020
[The multimorbid heart patient-an interdisciplinary challenge]Nikolaus Marx
Cardiovascular Research|December 9, 2025
The SOUL trial: another important study for the reduction of CV risk in individuals with type 2 diabetesNikolaus Marx
Journal of the American College of Cardiology|August 5, 2017
Leaving the Glucocentric View: Can SGLT2 Inhibitors Halt CVD in Patients With Type 2 Diabetes?Nikolaus Marx
Deutsche Medizinische Wochenschrift (1946)|January 19, 2021
[Dyslipidemia - common and important]Nikolaus Marx
Deutsche Medizinische Wochenschrift (1946)|January 23, 2015
[ST-elevation myocardial infarction: angiotensin receptor blockers are effective with preserved ejection fraction]Nikolaus Marx
Diabetes & Vascular Disease Research|December 14, 2011
Commentary on 'Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis' by Preiss et alNikolaus Marx
Current Hypertension Reports|January 16, 2002
Peroxisome proliferator-activated receptor gamma and atherosclerosisNikolaus Marx
Pageof 57

Showing results (11-20 of 566) with videos related to

Sort By:
Pageof 57
Deutsche Medizinische Wochenschrift (1946)|July 16, 2020
[Antithrombotic therapy in cardiovascular diseases]Nikolaus Marx
Cardiovascular Endocrinology & Metabolism|October 25, 2019
Heart failure: an underestimated therapeutic target in diabetesNikolaus Marx
Diabetes & Vascular Disease Research|October 30, 2008
PERISCOPE and the effect of pioglitazone on the progression of coronary artery disease in patients with diabetesNikolaus Marx
Herz|March 22, 2020
[The multimorbid heart patient-an interdisciplinary challenge]Nikolaus Marx
Cardiovascular Research|December 9, 2025
The SOUL trial: another important study for the reduction of CV risk in individuals with type 2 diabetesNikolaus Marx
Journal of the American College of Cardiology|August 5, 2017
Leaving the Glucocentric View: Can SGLT2 Inhibitors Halt CVD in Patients With Type 2 Diabetes?Nikolaus Marx
Deutsche Medizinische Wochenschrift (1946)|January 19, 2021
[Dyslipidemia - common and important]Nikolaus Marx
Deutsche Medizinische Wochenschrift (1946)|January 23, 2015
[ST-elevation myocardial infarction: angiotensin receptor blockers are effective with preserved ejection fraction]Nikolaus Marx
Diabetes & Vascular Disease Research|December 14, 2011
Commentary on 'Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis' by Preiss et alNikolaus Marx
Current Hypertension Reports|January 16, 2002
Peroxisome proliferator-activated receptor gamma and atherosclerosisNikolaus Marx
Pageof 57